Eli Lilly Halts Child Sepsis Study (AP)


AP - Eli Lilly & Co. has halted a pediatric study of its sepsis treatment Xigris, saying the drug was showing no benefit for children with the severe bloodstream infection and there was a sign of a possible serious side effect.

Read more...